Agion Antimicrobial Efficacy Against Coronavirusis Testedand Published
Feb 26, 2020
Leave a message
One of additives used in fabrics produced by our company for many years. In this new coronavirus(COVID-19) test,shows good results.
The technology is deployed in the EU, Canada and United States in FDA cleared N95 respirator
February 10, 2020
The novel coronavirus (nCoV) outbreak in China has prompted several inquiries to Sciessent regarding
the ability of Agion Antimicrobial to inactivate viruses. This white paper summarizes some university
and government research previously completed on the antiviral properties of Agion.
InitialResearch
The first half of the 2000’s was marked by viral outbreaks that
included H5N1 avian influenza, norovirus on cruise ships and the
SARS coronavirus. Sciessent(formerly Agion Technologies)engaged
with university researchers, industry partners and government
organizations to investigate the ability of Agion to inactivate viruses.
At the time the Chinese Center for Disease Control was looking for
approaches to control the coronavirus and evaluated the Agion
powder for efficacy. Around the same time Sciessent began working
with Prof. Charles Gerba at the University of Arizonaandto evaluate
antiviral properties of Agion.
Test Results
Chinese CDC(2003)
•Complete inactivation of SARS coronavirus in 2hours
•VERO E6 cell substrate, using virus CPE method
University of Arizona(2004)
•90% reduction of human coronavirus 229E in 1 hour
•99% reduction of human coronavirus 229E in 2 hours
•99.999% reduction of human coronavirus 229E in 24 hours
•TCID50 technique, monitoring MRC-5 cell monolayers for cytopathic effects
A Note on Terminology
Viruses are not living
organisms; they must enter
a living cell to multiply.
Therefore, antiviral agents
are said to “inactivate”
viruses, not “kill” them.
Chinese Academy of Agricultural Sciences(2006)
•99% reduction of H5N1 avian influenza in 10 minutes
•Klein-Defors suspension eradication test
Published Research
A portion of the above results were published by Professor Gerba and his team in the peer-reviewed
scientific journal Food and Environmental Virology:
Assessment of the Antiviral Properties of Zeolites Containing Metal Ions,
Food Environ Virol (2009) 1:37–41
Abstract
The antiviral properties of zeolite (sodium aluminosilicate) powders amended with metal
ions were assessed using human coronavirus 229E, feline infectious peritonitis virus (FIPV),
and feline calicivirus F-9. Zeolites containing silver and silver/copper caused significant
reductions of coronavirus 229E after 1 h in suspension. The silver/copper combination
yielded a >5.13-log10 reduction within 24 h. It was also the mosteffective (>3.18-log10)
against FIPV after 4 h. Other formulations were ineffective against FIPV. On plastic coupons
with incorporated silver/copper-zeolites, >1.7-log10 and >3.8-log10 reductions were
achieved for coronavirus 229E and feline calicivirus within 24 h, respectively. Silver/copper
zeolite reduced titers of all viruses tested, suggesting that it may be effective against
related pathogens of interest [i.e., SARS coronavirus, other coronaviruses, human
norovirus (calicivirus)]. Of note, it was effective against both enveloped and nonenveloped
viruses. Metal-zeolites could therefore possibly be used in applications to reduce virus
contamination of fomites and thus the spread of viral diseases.
Note: Springer Nature is making Coronavirus research free, including the above article.
Agion in Polyester Fiber
During this time Sciessent worked with Foss Manufacturing (now Foss Performance Materials) to
develop a polyester fiber with Agion embedded into the fiber itself. The fiber, named Fosshield, was
incorporated into N95 respirator media as an approach to limit contamination of the respirator by
the wearer or those around them. Further antiviral efficacy testing was performed on the respirator
media construction.
N95 Respirator Media Test Results
•99.98% reduction of coronavirus in 4 hours*
•99.6% reduction of adenovirus in 1 hour*
•99.999% reduction of haemophilus influenzae in 1 hour*
•99.8% reduction of feline calicivirus (norovirus surrogate) in 4 hours*
*Results based on testing of samples containing Agion Antimicrobial
Once proven, the media was manufactured by Nexera Medical into an N95 respirator, which
underwent extensive testing and was submitted to the FDA in 2009. The Nexera Spectrashield
surgical respirator was cleared by NIOSH and received a 510(k) from the Food and Drug
Administration in 2011and has since been cleared in Canada and the European Union.
Approved claims for the European Union:
http://www.nexeramed.com/nfiles/news_110711_1.php
Approved claims for Canada:
http://www.nexeramed.com/cfiles/regulatory.php?region=CA
Application Options
Agion is a versatile material that can be mixedinto coatings,
compounded intoplastics, and applied to textilesusing several
processes:
Topical–Fastest and most versatile
•Pad/Dry/Cure
•Exhaust
•Dip/Extract
•Yarn Package
Embedded
•
Filament or staple fiber spinning
•Melt blown nonwoven
•Spunbond nonwoven
Contacts
Sciessent: wayne@kmtextile.net
The Agion® Antimicrobial is presently registered by the United States Environmental Protection Agency as a preservative and bacteriostatic
agent for use in treated articles under 40 CFR 152.25a. The information presented herein is not intended to support or endorse public health
claims for treated articles. The Agion Antimicrobial is also used in medical devices under the Food and Drug Administration in the US; those
medical device claims are based onsafety and efficacy testing and are limited to those approved by FDA. In the EU, the Agion Antimicrobial
is used in medical devices under the Medical Device Directive: those medical device claims are based on safety and efficacy testing and are
limited tothose approved by the designated Competent Authorities and/or Notified Bodies

